|
|
|
|
Elutia Inc (NASDAQ: ELUT) |
|
|
|
| |
Elutia Inc 's Tangible Leverage Ratio
ELUT's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth
|
Select the Comparisons :
|
|
Select the Ratio:
|
Tangible Leverage Ratio ▼
|
Tangible Leverage Ratio ▼
|
| ELUT Tangible Leverage Ratio |
(Mar 31 2025)
Q1 |
(Dec 31 2024)
Q4 |
(Sep 30 2024)
Q3 |
(Jun 30 2024)
Q2 |
(Mar 31 2024)
Q3 |
| Y / Y Tangible Equity Change |
- |
- |
- |
- |
- |
| Y / Y Total Liabilities Change |
-10.9 % |
12.4 % |
16.53 % |
63.95 % |
30.47 % |
| Tangible Leverage Ratio MRQ |
- |
- |
- |
- |
- |
| ELUT's Total
Ranking |
# |
# |
# |
# |
# |
| Seq. Tangible Equity Change |
- |
- |
- |
- |
- |
| Seq. Total Liabilities Change |
-9.91 % |
-7.43 % |
-16.63 % |
28.14 % |
13.65 % |
| Tangible Leverage Ratio first quarter 2025 Company Ranking |
| Within: |
No. |
| Biotechnology & Pharmaceuticals Industry |
# |
| Healthcare Sector |
# |
| Overall Market |
# |
| Tangible Leverage Ratio Statistics |
| High |
Average |
Low |
| 0 |
0 |
0 |
|
|
|
Cumulative Elutia Inc 's Tangible Leverage Ratio
ELUT's Tangible Leverage Ratio for the trailling 12 Months
ELUT Tangible Leverage Ratio |
(Mar 31 2025)
12 Months |
(Dec 31 2024)
12 Months |
(Sep 30 2024)
12 Months |
(Jun 30 2024)
12 Months |
(Mar 31 2024)
12 Months |
| Y / Y Tangible Equity TTM Growth |
- |
- |
- |
- |
- |
| Y / Y Total Liabilities TTM Growth |
18.21 % |
29.72 % |
30.23 % |
37.96 % |
31.71 % |
| Tangible Leverage Ratio TTM |
- |
- |
- |
- |
- |
| Total Ranking TTM |
|
|
|
|
|
| Seq. Tangible Equity TTM Growth |
- |
- |
- |
- |
- |
| Seq. Total Liabilities TTM Growth |
-2.51 % |
2.58 % |
3.72 % |
13.97 % |
6.98 % |
On the trailing twelve months basis During the 12 months period ending Q1 2025 company had stockholder deficit. Tangible Leverage Ratio is the average cumulative value over the last four quarters.
Among companies in the Biotechnology & Pharmaceuticals industry ELUT recorded the lowest Tangible Leverage Ratio. While total ranking remained unchanged compared to previous 12 month period at no. 0.
Explain Tangible Leverage Ratio?
What is ELUT Market Share?
What are ELUT´s Total Liabilities?
| TTM Tangible Leverage Ratio Company Ranking |
| Within: |
No. |
| Within the Biotechnology & Pharmaceuticals Industry |
# |
| Healthcare Sector |
# |
| Within the Market |
# |
| trailing twelve months Tangible Leverage Ratio Statistics |
| High |
Average |
Low |
| 0 |
0 |
0 | |
|
|
| Companies with similar Tangible Leverage Ratio in the quarter ending Mar 31 2025, within Biotechnology & Pharmaceuticals Industry | Tangible Leverage Ratio | Mar 31 2025 MRQ Total Liabilities | Mar 31 2025 MRQ Tangible Equity |
|
Date modified: 2025-05-15T07:40:47+00:00
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
